FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS
申请人:WARNER-LAMBERT COMPANY
公开号:EP1144415A2
公开(公告)日:2001-10-17
FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR
申请人:Millennium Pharmaceuticals, Inc.
公开号:EP1377549A1
公开(公告)日:2004-01-07
US6951848B2
申请人:——
公开号:US6951848B2
公开(公告)日:2005-10-04
[EN] FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS<br/>[FR] HETEROCYCLES FONCTIONNALISES EN TANT QUE MODULATEURS DES RECEPTEURS DE CHIMIOKINES
申请人:WARNER LAMBERT CO
公开号:WO2000042045A2
公开(公告)日:2000-07-20
The present invention is a novel series of functionalized heterocycles as chemokine receptor modulators of Formula (I) useful as modulators of chemokine receptor activity. The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the prepartion of the final products, pharmaceutical compositions containing the final products are also taught.
[EN] FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR<br/>[FR] HETEROCYCLES FONCTIONNALISES EN TANT QUE MODULATEURS DE LA FONCTION DU RECEPTEUR DE CHIMIOKINES ET PROCEDES DE MISE EN OEUVRE
申请人:MILLENNIUM PHARM INC
公开号:WO2002072549A1
公开(公告)日:2002-09-19
Disclosed are novel compounds having the formula (I) or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula (I). In particular embodiments, the invention is a method for treating a patient infected with HIV.